Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
24,701,460
-
Total 13F shares
-
21,843,759
-
Share change
-
-37,107
-
Total reported value
-
$2,599,636,515
-
Put/Call ratio
-
71%
-
Price per share
-
$119.01
-
Number of holders
-
210
-
Value change
-
-$32,819,360
-
Number of buys
-
94
-
Number of sells
-
117
Institutional Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) as of Q3 2023
As of 30 Sep 2023,
ICU MEDICAL INC/DE - Common Stock (ICUI) was held by
210 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,843,759 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, T. Rowe Price Investment Management, Inc., VANGUARD GROUP INC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, FULLER & THALER ASSET MANAGEMENT, INC., JPMORGAN CHASE & CO, MORGAN STANLEY, and VICTORY CAPITAL MANAGEMENT INC.
This page lists
213
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.